These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32145336)

  • 1. Dyspnea as a Fatigue-Promoting Factor in ALS and the Role of Objective Indicators of Respiratory Impairment.
    Vogt S; Schreiber S; Pfau G; Kollewe K; Heinze HJ; Dengler R; Petri S; Vielhaber S; Brinkers M
    J Pain Symptom Manage; 2020 Aug; 60(2):430-438.e1. PubMed ID: 32145336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.
    Vogt S; Schreiber S; Heinze HJ; Dengler R; Petri S; Vielhaber S
    Health Qual Life Outcomes; 2019 Jun; 17(1):95. PubMed ID: 31159830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment.
    Vogt S; Schreiber S; Kollewe K; Körner S; Heinze HJ; Dengler R; Petri S; Vielhaber S
    Respir Med; 2019; 154():116-121. PubMed ID: 31234039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear.
    Morélot-Panzini C; Perez T; Sedkaoui K; de Bock E; Aguilaniu B; Devillier P; Pignier C; Arnould B; Bruneteau G; Similowski T
    Respir Med; 2018 Dec; 145():1-7. PubMed ID: 30509697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyspnea in Amyotrophic Lateral Sclerosis: Rasch-Based Development and Validation of a Patient-Reported Outcome (DALS-15).
    Vogt S; Petri S; Dengler R; Heinze HJ; Vielhaber S
    J Pain Symptom Manage; 2018 Nov; 56(5):736-745.e2. PubMed ID: 30145215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.
    Helleman J; Kruitwagen-van Reenen ET; Bakers J; Kruithof WJ; van Groenestijn AC; Jaspers Focks RJH; de Grund A; van den Berg LH; Visser-Meily JMA; Beelen A
    J Neurol; 2020 Nov; 267(11):3310-3318. PubMed ID: 32577867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis.
    Young C; Ealing J; McDermott C; Williams T; Al-Chalabi A; Majeed T; Roberts R; Mills R; Tennant A;
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):390-398. PubMed ID: 34709092
    [No Abstract]   [Full Text] [Related]  

  • 8. [Respiratory domain of revised amyotrophic lateral sclerosis. Functional Rating Scale].
    Lima SE; Pessolano FA; Monteiro SG; De Vito EL
    Medicina (B Aires); 2009; 69(5):547-53. PubMed ID: 19897441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.
    Young CA; Chaouch A; Mcdermott CJ; Al-Chalabi A; Chhetri SK; Talbot K; Harrower T; Orrell RW; Annadale J; Hanemann CO; Scalfari A; Tennant A; Mills R;
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):475-485. PubMed ID: 38465877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of dyspnea in patients with amyotrophic lateral sclerosis.
    Lechtzin N; Lange DJ; Davey C; Becker B; Mitsumoto H
    Muscle Nerve; 2007 Jan; 35(1):98-102. PubMed ID: 17029274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis.
    Tilanus TBM; Groothuis JT; TenBroek-Pastoor JMC; Feuth TB; Heijdra YF; Slenders JPL; Doorduin J; Van Engelen BG; Kampelmacher MJ; Raaphorst J
    Respir Res; 2017 Jul; 18(1):144. PubMed ID: 28743265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead.
    Blackhall LJ
    Muscle Nerve; 2012 Mar; 45(3):311-8. PubMed ID: 22334165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Assessment of ALS Patients: A Nationwide Survey of Current Dutch Practice.
    Tilanus TBM; Groothuis JT; Ten Broek-Pastoor JMC; Doorduin J; van Engelen BGM; Kampelmacher MJ; Raaphorst J
    J Neuromuscul Dis; 2018; 5(4):431-438. PubMed ID: 30372689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis.
    Fantini R; Mandrioli J; Zona S; Antenora F; Iattoni A; Monelli M; Fini N; Tonelli R; Clini E; Marchioni A
    Respirology; 2016 Jul; 21(5):932-8. PubMed ID: 26994409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a new ALS specific respiratory questionnaire: the ARES score.
    Heiman-Patterson TD; Sherman MS; Yu D; Jackson CE; George A; Kasarskis EJ;
    Amyotroph Lateral Scler Frontotemporal Degener; 2021; 22(sup1):48-53. PubMed ID: 34348538
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing Inspiratory Muscle Strength for Early Detection of Respiratory Failure in Motor Neuron Disease: Should We Use MIP, SNIP, or Both?
    Janssens JP; Adler D; Iancu Ferfoglia R; Poncet A; Genton Graf L; Leuchter I; Escher Imhof M; Héritier Barras AC
    Respiration; 2019; 98(2):114-124. PubMed ID: 31018212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory function and cognitive profile in amyotrophic lateral sclerosis.
    Huynh W; Sharplin LE; Caga J; Highton-Williamson E; Kiernan MC
    Eur J Neurol; 2020 Apr; 27(4):685-691. PubMed ID: 31750604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-of-Life Care of Patients With Amyotrophic Lateral Sclerosis and Other Nonmalignant Diseases.
    Tiirola A; Korhonen T; Surakka T; Lehto JT
    Am J Hosp Palliat Care; 2017 Mar; 34(2):154-159. PubMed ID: 26450877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The checklist individual strength (CIS20-R) in patients with amyotrophic lateral sclerosis - a longitudinal study.
    Panitz S; Kornhuber M; Hanisch F
    Acta Neurol Scand; 2015 Jun; 131(6):372-80. PubMed ID: 25639482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment.
    Lechtzin N; Rothstein J; Clawson L; Diette GB; Wiener CM
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):5-13. PubMed ID: 12061943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.